Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Pruritus Therapeutics Market, 2014 - 2022 (USD Billion)

2.2. Global Pruritus Therapeutics Market: Snapshot

Chapter 3. Pruritus Therapeutics Market  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Pruritus Therapeutics Market drivers: Impact Analysis

3.3.2. increasing prevalence of atopic dermatitis

3.3.3. Development of new drug and a strong pipeline

3.4. Global Pruritus Therapeutics Market Restraints: Impact Analysis


3.4.1. Lack of awareness about pruritus

3.5. Opportunities


3.5.1. Untapped market and increasing number of patent expiry of pruritus drugs

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, by therapeutic segment

3.7.2. Market Attractiveness Analysis, by Regional Segment

Chapter 4. Global Pruritus Therapeutics Market  Competitive Landscape


4.1. Company Market Share, 2014 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Source Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Therapeutic And Regional Expansion

4.3. Technology Portfolio

4.4. Patent Analysis (2011-2015)


4.4.1. Patent Trend

4.4.2. Patent Share By Company

4.4.3. By Region

Chapter 5. Global Pruritus Therapeutics Market  Therapeutic Analysis


5.1. Global Pruritus Therapeutics Market: Therapeutic Segment Overview


5.1.1. Global Pruritus Therapeutics Market Revenue Share, By Therapeutic Segment, 2014 And 2022

5.2. Antihistamines


5.2.1. Global Pruritus Therapeutics Market For Antihistamines, 2014 - 2022 (USD Billion)

5.3. Topical Corticosteroids


5.3.1. Global Pruritus Therapeutics Market For Topical Corticosteroids, 2014 - 2022 (USD Billion

5.4. Opioid Receptor Antagonists


5.4.1. Global Pruritus Therapeutics Market For Opioid Receptor Antagonists, 2014 - 2022 (USD Billion)

5.5. Topical Immunomodulators


5.5.1. Global Pruritus Therapeutics Market For Topical Immunomodulators, 2014 - 2022 (USD Billion)

5.6. Antidepressants


5.6.1. Global Pruritus Therapeutics Market For Antidepressants , 2014 - 2022 (USD Billion)

5.7. Immunosuppressants


5.7.1. Global Pruritus Therapeutics Market For Immunosuppressants, 2014 - 2022 (USD Billion)

5.8. Topical Local Anesthetics


5.8.1. Global Pruritus Therapeutics Market For Topical Local Anesthetics, 2014 - 2022 (USD Billion)

5.9. Cannabinoid Receptors


5.9.1. Global Pruritus Therapeutics Market For Cannabinoid Receptors, 2014 - 2022 (USD Billion)

5.10. Others


5.10.1. Global Pruritus Therapeutics Market For others, 2014 - 2022 (USD Billion)

Chapter 6. Global Pruritus Therapeutics Market  Regional Segment Analysis


6.1. Global Pruritus Therapeutics Market: Regional Overview


6.1.1. Global Pruritus Therapeutics Market Revenue Share, By Region, 2014 And 2020

6.2. North America


6.2.1. North America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)

6.2.2. U.S.


6.2.2.1. U.S. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.3. Europe


6.3.1. Europe Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)

6.3.2. U.K.


6.3.2.1. U.K. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.3.3. Germany


6.3.3.1. Germany Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.3.4. France


6.3.4.1. France Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.4. Asia Pacific


6.4.1. Asia Pacific Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)

6.4.2. India


6.4.2.1. India Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.4.3. China


6.4.3.1. China Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.4.4. Japan


6.4.4.1. Japan Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)



6.5. Latin America


6.5.1. Latin America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)

6.5.2. Brazil


6.5.2.1. Brazil Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million)

6.6. Middle East and Africa


6.6.1. Middle East and Africa Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion)

Chapter 7. Company Profile


7.1. Allergan Inc.


7.1.1. Overview

7.1.2. Financials

7.1.3. Technology Portfolio

7.1.4. Business Strategy

7.1.5. Recent Developments

7.2. Amgen Inc.


7.2.1. Overview

7.2.2. Financials

7.2.3. Technology Portfolio

7.2.4. Business Strategy

7.2.5. Recent Developments

7.3. Astellas Pharma Inc.


7.3.1. Overview

7.3.2. Financials

7.3.3. Technology Portfolio

7.3.4. Business Strategy

7.3.5. Recent Developments

7.4. CARA Therapeutics


7.4.1. Overview

7.4.2. Financials

7.4.3. Technology Portfolio

7.4.4. Business Strategy

7.4.5. Recent Developments

7.5. Novartis AG


7.5.1. Financials

7.5.2. Technology Portfolio

7.5.3. Business Strategy

7.5.4. Recent Developments

7.6. Teva Pharmaceutical Industries Ltd.


7.6.1. Financials

7.6.2. Technology Portfolio

7.6.3. Business Strategy

7.6.4. Recent Developments

7.7. Ajanta Pharma ltd.


7.7.1. Overview

7.7.2. Financials

7.7.3. Technology Portfolio

7.7.4. Business Strategy

7.7.5. Recent Developments

7.8. Abbot lab


7.8.1. Overview

7.8.2. Financials

7.8.3. Technology Portfolio

7.8.4. Business Strategy

7.8.5. Recent Developments

7.9. GlaxoSmithKline plc.


7.9.1. Overview

7.9.2. Financials

7.9.3. Technology Portfolio

7.9.4. Business Strategy

7.9.5. Recent Developments

7.10. Galderma


7.10.1. Overview

7.10.2. Financials

7.10.3. Technology Portfolio

7.10.4. Business Strategy

7.10.5. Recent Developments